The Generic Drugs Market size was valued at USD 431.15 Billion in 2023 and the total Generic Drugs Market revenue is expected to grow at a CAGR of 5.22% from 2024 to 2030, reaching nearly USD 615.72 Billion.Generic Drugs Market Overview:
A generic drug is a pharmaceutical product that matches a brand-name counterpart in dosage, strength, administration route, quality, and intended use but lacks the brand name. Generic drugs are often more cost-effective than their brand-name counterparts. The generic drugs market is expanding owing to the rising demand resulting from the expiration of patents for brand-name medications. Additionally, the increasing global healthcare costs are fostering a positive generic drugs market outlook. The growth is further propelled by the rising elderly population worldwide, characterized by various chronic conditions like cardiovascular diseases, diabetes, and respiratory disorders.To know about the Research Methodology :- Request Free Sample Report
Generic Drugs Market Dynamics:
The global generic drugs market dynamics are thoroughly studied and explained in the MMR report, which helps reader to understand emerging generic drugs market trends, drivers, restraints, opportunities, and challenges at global and regional level for the generic drugs market globally. Some of the drivers and restraints are illustrate below, their detailed explanation is discussed in the report with other supporting: One of the key drivers of the generic drugs market is the increased incidence of chronic diseases. As more people are diagnosed with chronic conditions, they seek out more treatment options. Branded medications are more expensive, but generic drugs are less expensive and have the same chemical composition as branded drugs. Patients prefer generic medications over branded drugs because generic drugs are less expensive and have the same chemical composition and strength. When a patient has a chronic illness, the treatment lasts longer, this leads to a rise in generic medicine sales. According to the WHO (World Health Organization), chronic disease-related fatalities are expected to rise by 17% over the next ten years. In addition, chronic diseases will account for nearly three-quarters of all fatalities globally by 2022. However, despite the reduction in prices brought about by the entry of generic drugs compared to branded counterparts, patients are not reaping the benefits of lower costs due to the involvement of intermediary entities like pharmacy benefit managers (PBMs) such as Express Scripts, CVS Caremark, and OptumRx, as well as insurers like United Health Group, Cigna, and CVS Health. These intermediaries engage in practices such as spread pricing, profit-driven formulary design, and copay drawbacks, resulting in overpayment for generic drugs. Instead of passing on the full savings to consumers, these practices generate financial gains, contributing to a decline in the prescription of generic drugs market.Generic Drugs Market Segment Analysis:
Based on the Product, the global generic drugs market is sub-segmented into Simple Generics, Super Generics and Biosimilars. The Super Generics segment held the largest market share of nearly 38% in 2023. Value added generics, novel therapeutic entities, and hybrids are all terms used to describe super generic drugs. The composition or distribution technique of super generic products differs from that of the original product. Biosimilars have the same clinical impact as generics, but they can only be as close to the original branded medication as validation technology can confirm. Biosimilar developers will be pushed to adhere to established techniques for showing a high degree of similarity as they focus on proteins of greater complexity, which need higher prices and even more sophisticated manufacturing.In terms of Application, the global generic drugs market is sub-segmented into Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drug, Respiratory Products and Others. The Central Nervous System Drugs segment held the largest market share in 2023. Some of the main drivers estimated to fuel market growth include increased awareness about mental health, social acceptance of mentally ill individuals, and access to improved healthcare choices. During the forecast period, cost-effective and readily available pharmaceuticals are likely to drive generic drug market growth. Cardiovascular diseases, which include heart failure, circulation disorders, hypertension, cholesterol, dyslipidemia, angina, arrhythmias, and stroke, are among the major causes of death globally. Due to several cardiovascular drug patent expirations, the cardiovascular segment accounts for more than 5% of the global generic drugs market. The broader healthcare sector, as well as generic medicine makers, are benefiting from growing global population and ageing demographics.
Generic Drugs Market Regional Analysis:
North America held the largest generic drugs market share of 33.21% in 2023. The existence of many players in North American countries explains the high income, as they continue to focus on the introduction of new goods and the market, as well as the prescription pattern in the United States, which is dominated by branded generic pharmaceuticals. As a result, the global generic drugs market is estimated to grow during the forecast period. Asia Pacific is expected to grow at the highest CAGR of 6.42% in the generic drugs market during the forecast period. This can be attributable to Asia's reduced manufacturing prices and highly skilled workforce. According to MMR, India has the second-largest number of FDA-approved generic medication manufacturing plants outside of the United States. Additionally, India's production costs are 33% lower than those in the United States, making generics more accessible in these countries. With an exceptionally low percentage of generic drug use, Asia-Pacific has kept a major emphasis on increasing medicine procurement at more affordable prices, even if this involves buying from non-traditional sources. As a result, growing markets like India and China are contributing to the growth of the generic drugs market. Key Players in Generic Drugs Market Growth Strategy: Strategic and non-strategic initiatives such as mergers, and acquisitions partnerships, by generic drugs market key players are further expected to contribute to generic drugs market growth. For example, in June 2022, Pfizer Inc. announced the submission of a New Drug Application (NDA) seeking approval for PAXLOVID™ (tablets and ritonavir tablets) to the U.S. FDA. This application targets patients facing a high risk of severe illness from COVID-19. In May 2023, Teva Pharmaceuticals Industries Ltd. revealed its plan to showcase data illustrating UZEDY (risperidone) extended-release injectable suspension designed for subcutaneous use.Global Generic Drugs Market Scope: Inquiry Before Buying
Global Generic Drugs Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 431.15 Bn. Forecast Period 2024 to 2030 CAGR: 5.22 % Market Size in 2030: US $ 615.72 Bn. Segments Covered: by Product Simple Generics Super Generics Biosimilars by Application Cardiovascular Products Anti-Infective Drugs Anti-Arthritis Drugs Central Nervous System Drugs Anti-Cancer Drug Respiratory Products Others by Distribution Channel Hospitals Pharmacies Private Clinics Drug Stores Retail Pharmacies Others Global Generic Drugs Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Generic Drugs Market Key Players:
North America Generic Drugs Market Top Players: 1. Mylan N.V. - (USA) 2. Par Pharmaceuticals- (USA) 3. Pfizer - (USA) 4. Baxter International Inc. - (USA) 5. Eli Lilly and Company - (USA) 6. Abbott Laboratories - (USA) 7. Apotex Inc. - (Canada) 8. Apotex Corp. - (USA) Europe Generic Drugs Market Top Players 1. Endo Pharmaceuticals - (Ireland) 2. Teva Pharmaceutical Industries Ltd- (Israel) 3. STADA Arzneimittel AG - (Germany) 4. GlaxoSmithKline Plc. - (United Kingdom) 5. Novartis International AG - (Switzerland) APAC Generic Drugs Market Top Players: 1. Sun Pharma - (India) 2. Lupin Pharmaceuticals - (India) 3. Dr Reddy’s - (India) 4. ASKA Pharmaceutical Co., Ltd. - (Japan) 5. Taisho Pharmaceutical Holdings Co Ltd - (Japan) 6. Aurobindo Pharma Limited - (India) 7. Hikma Pharmaceuticals PLC - (Jordan) 8. Torrent Pharmaceuticals Ltd - (India) FAQs: 1. What are the growth drivers for the market? Ans. Generic drugs are typically more affordable than their brand-name counterparts play a crucial role in driving the market. 2. What is the major restraint for the market growth? Ans. Lack of transparency regarding the actual prices of generic drugs is expected to be the major restraining factor for the market growth. 3. Which region is expected to lead the global market during the forecast period? Ans. North America is expected to lead the global market during the forecast period. 4. What is the projected market size & and growth rate of the Market? Ans. The Generic Drugs Market size was valued at USD 431.15 Billion in 2023 and the total Market revenue is expected to grow at a CAGR of 5.22% from 2024 to 2030, reaching nearly USD 615.72 Billion. 5. What segments are covered in the Market report? Ans. The segments covered in the market report are Product, Distribution Channel, Application, and Region.
1. Generic Drugs Market: Research Methodology 2. Generic Drugs Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Generic Drugs Market: Dynamics 3.1. Generic Drugs Market Trends by Region 3.2. Generic Drugs Market Dynamics by Region 3.2.1. Generic Drugs Market Drivers 3.2.2. Generic Drugs Market Restraints 3.2.3. Generic Drugs Market Opportunities 3.2.4. Generic Drugs Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Regulatory Landscape by Region 3.5.1. Global 3.5.2. North America 3.5.3. Europe 3.5.4. Asia Pacific 3.5.5. Middle East and Africa 3.5.6. South America 3.6. The Global Pandemic Impact on Generic Drugs Market 4. Generic Drugs Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 4.1. Generic Drugs Market Size and Forecast, By Product (2023-2030) 4.1.1. Simple Generics 4.1.2. Super Generics 4.1.3. Biosimilars 4.2. Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 4.2.1. Hospitals 4.2.2. Pharmacies 4.2.3. Private Clinics 4.2.4. Drug Stores 4.2.5. Retail Pharmacies 4.2.6. Others 4.3. Generic Drugs Market Size and Forecast, by Application (2023-2030) 4.3.1. Cardiovascular Products 4.3.2. Anti-Infective Drugs 4.3.3. Anti-Arthritis Drugs 4.3.4. Central Nervous System Drugs 4.3.5. Anti-Cancer Drug 4.3.6. Respiratory Products 4.3.7. Others 4.4. Generic Drugs Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Generic Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 5.1. North America Generic Drugs Market Size and Forecast, By Product (2023-2030) 5.1.1. Simple Generics 5.1.2. Super Generics 5.1.3. Biosimilars 5.2. North America Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.2.1. Hospitals 5.2.2. Pharmacies 5.2.3. Private Clinics 5.2.4. Drug Stores 5.2.5. Retail Pharmacies 5.2.6. Others 5.3. North America Generic Drugs Market Size and Forecast, by Application (2023-2030) 5.3.1. Cardiovascular Products 5.3.2. Anti-Infective Drugs 5.3.3. Anti-Arthritis Drugs 5.3.4. Central Nervous System Drugs 5.3.5. Anti-Cancer Drug 5.3.6. Respiratory Products 5.3.7. Others 5.4. Generic Drugs Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Generic Drugs Market Size and Forecast, By Product (2023-2030) 5.4.1.1.1. Simple Generics 5.4.1.1.2. Super Generics 5.4.1.1.3. Biosimilars 5.4.1.2. United States Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.1.2.1. Hospitals 5.4.1.2.2. Pharmacies 5.4.1.2.3. Private Clinics 5.4.1.2.4. Drug Stores 5.4.1.2.5. Retail Pharmacies 5.4.1.2.6. Others 5.4.1.3. United States Generic Drugs Market Size and Forecast, by Application (2023-2030) 5.4.1.3.1. Cardiovascular Products 5.4.1.3.2. Anti-Infective Drugs 5.4.1.3.3. Anti-Arthritis Drugs 5.4.1.3.4. Central Nervous System Drugs 5.4.1.3.5. Anti-Cancer Drug 5.4.1.3.6. Respiratory Products 5.4.1.3.7. Others Canada 5.4.1.4. Canada Generic Drugs Market Size and Forecast, By Product (2023-2030) 5.4.1.4.1. Simple Generics 5.4.1.4.2. Super Generics 5.4.1.4.3. Biosimilars 5.4.1.5. Canada Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.1.5.1. Hospitals 5.4.1.5.2. Pharmacies 5.4.1.5.3. Private Clinics 5.4.1.5.4. Drug Stores 5.4.1.5.5. Retail Pharmacies 5.4.1.5.6. Others 5.4.1.6. Canada Generic Drugs Market Size and Forecast, by Application (2023-2030) 5.4.1.6.1. Cardiovascular Products 5.4.1.6.2. Anti-Infective Drugs 5.4.1.6.3. Anti-Arthritis Drugs 5.4.1.6.4. Central Nervous System Drugs 5.4.1.6.5. Anti-Cancer Drug 5.4.1.6.6. Respiratory Products 5.4.1.6.7. Others 5.4.2. Mexico 5.4.2.1. Mexico Generic Drugs Market Size and Forecast, By Product (2023-2030) 5.4.2.1.1. Simple Generics 5.4.2.1.2. Super Generics 5.4.2.1.3. Biosimilars 5.4.2.2. Mexico Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 5.4.2.2.1. Hospitals 5.4.2.2.2. Pharmacies 5.4.2.2.3. Private Clinics 5.4.2.2.4. Drug Stores 5.4.2.2.5. Retail Pharmacies 5.4.2.2.6. Others 5.4.2.3. Mexico Generic Drugs Market Size and Forecast, by Application (2023-2030) 5.4.2.3.1. Cardiovascular Products 5.4.2.3.2. Anti-Infective Drugs 5.4.2.3.3. Anti-Arthritis Drugs 5.4.2.3.4. Central Nervous System Drugs 5.4.2.3.5. Anti-Cancer Drug 5.4.2.3.6. Respiratory Products 5.4.2.3.7. Others 6. Europe Generic Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 6.1. Europe Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.2. Europe Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.3. Europe Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4. Europe Generic Drugs Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.1.2. United Kingdom Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.1.3. United Kingdom Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.2. France 6.4.2.1. France Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.2.2. France Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.2.3. France Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.3.2. Germany Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.3.3. Germany Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.4.2. Italy Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.4.3. Italy Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.5.2. Spain Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.5.3. Spain Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.6.2. Sweden Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.6.3. Sweden Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.7.2. Austria Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.7.3. Austria Generic Drugs Market Size and Forecast, by Application (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Generic Drugs Market Size and Forecast, By Product (2023-2030) 6.4.8.2. Rest of Europe Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 6.4.8.3. Rest of Europe Generic Drugs Market Size and Forecast, by Application (2023-2030) 7. Asia Pacific Generic Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.2. Asia Pacific Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.3. Asia Pacific Generic Drugs Market Size and Forecast, by Application(2023-2030) 7.4. Asia Pacific Generic Drugs Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.1.2. China Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.1.3. China Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.1.4. China Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.1.5. China Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.1.6. China Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.2. Japan 7.4.2.1. Japan Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.2.2. Japan Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.2.3. Japan Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.3. India 7.4.3.1. India Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.3.2. India Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.3.3. India Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.4. Australia 7.4.4.1. Australia Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.4.2. Australia Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.4.3. Australia Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.5. Indonesia 7.4.5.1. Indonesia Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.5.2. Indonesia Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.5.3. Indonesia Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.6. Malaysia 7.4.6.1. Malaysia Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.6.2. Malaysia Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.6.3. Malaysia Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.7. Vietnam 7.4.7.1. Vietnam Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.7.2. Vietnam Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.7.3. Vietnam Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.8. Taiwan 7.4.8.1. Taiwan Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.8.2. Taiwan Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.8.3. Taiwan Generic Drugs Market Size and Forecast, by Application (2023-2030) 7.4.9. Rest of Asia Pacific 7.4.9.1. Rest of Asia Pacific Generic Drugs Market Size and Forecast, By Product (2023-2030) 7.4.9.2. Rest of Asia Pacific Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 7.4.9.3. Rest of Asia Pacific Generic Drugs Market Size and Forecast, by Application (2023-2030) 8. Middle East and Africa Generic Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030 8.1. Middle East and Africa Generic Drugs Market Size and Forecast, By Product (2023-2030) 8.2. Middle East and Africa Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.3. Middle East and Africa Generic Drugs Market Size and Forecast, by Application (2023-2030) 8.4. Middle East and Africa Generic Drugs Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Generic Drugs Market Size and Forecast, By Product (2023-2030) 8.4.1.2. South Africa Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.1.3. South Africa Generic Drugs Market Size and Forecast, by Application (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Generic Drugs Market Size and Forecast, By Product (2023-2030) 8.4.2.2. GCC Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.2.3. GCC Generic Drugs Market Size and Forecast, by Application (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Generic Drugs Market Size and Forecast, By Product (2023-2030) 8.4.3.2. Nigeria Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.3.3. Nigeria Generic Drugs Market Size and Forecast, by Application (2023-2030) 8.4.3.4. 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Generic Drugs Market Size and Forecast, By Product (2023-2030) 8.4.4.2. Rest of ME&A Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 8.4.4.3. Rest of ME&A Generic Drugs Market Size and Forecast, by Application (2023-2030) 9. South America Generic Drugs Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030 9.1. South America Generic Drugs Market Size and Forecast, By Product (2023-2030) 9.2. South America Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 9.3. South America Generic Drugs Market Size and Forecast, by Application (2023-2030) 9.4. South America Generic Drugs Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Generic Drugs Market Size and Forecast, By Product (2023-2030) 9.4.1.2. Brazil Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 9.4.1.3. Brazil Generic Drugs Market Size and Forecast, by Application (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Generic Drugs Market Size and Forecast, By Product (2023-2030) 9.4.2.2. Argentina Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 9.4.2.3. Argentina Generic Drugs Market Size and Forecast, by Application (2023-2030) 9.4.3. Argentina 9.4.4. Rest Of South America 9.4.4.1. Rest Of South America Generic Drugs Market Size and Forecast, By Product (2023-2030) 9.4.4.2. Rest Of South America Generic Drugs Market Size and Forecast, By Distribution Channel (2023-2030) 9.4.4.3. Rest Of South America Generic Drugs Market Size and Forecast, by Application (2023-2030) 10. Global Generic Drugs Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. End-User 10.3.3. Revenue (2023) 10.3.4. Company Locations 10.4. Leading Generic Drugs Market Companies, by market capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Teva Pharmaceutical Industries Ltd - (Israel) 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Scale of Operation (small, medium, and large) 11.1.7. Details on Partnership 11.1.8. Regulatory Accreditations and Certifications Received by Them 11.1.9. Awards Received by the Firm 11.1.10. Recent Developments 11.2. Mylan N.V. - (USA) 11.3. Sun Pharma - (India) 11.4. Par Pharmaceuticals - (USA) 11.5. Endo Pharmaceuticals - (Ireland) 11.6. Lupin Pharmaceuticals - (India) 11.7. Dr Reddy’s - (India) 11.8. Pfizer - (USA) 11.9. STADA Arzneimittel AG - (Germany) 11.10. Baxter International Inc. - (USA) 11.11. Eli Lilly and Company - (USA) 11.12. GlaxoSmithKline Plc. - (United Kingdom) 11.13. Pfizer Inc. - (USA) 11.14. ASKA Pharmaceutical Co., Ltd. - (Japan) 11.15. Taisho Pharmaceutical Holdings Co Ltd - (Japan) 11.16. Abbott Laboratories - (USA) 11.17. Apotex Inc. - (Canada) 11.18. Novartis International AG - (Switzerland) 11.19. Aurobindo Pharma Limited - (India) 11.20. Hikma Pharmaceuticals PLC - (Jordan) 11.21. Torrent Pharmaceuticals Ltd - (India) 11.22. Apotex Corp. - (USA) 12. Generic Drugs Market Key Findings 13. Industry Recommendations 14. Terms and Glossary